Chase Therapeutics
Washington, District of Columbia, United States • 1-10 Employees
Company overview
| Headquarters | 1825 K ST NW, WASHINGTON, Washington DC 20006, us |
| Phone number | +12025688831 |
| Website | |
| SIC | 283 |
| Employees | 1-10 |
| Socials |
Key Contact at Chase Therapeutics
Kathleen Clarence Smith
Co Founder and Board Chair
About Chase Therapeutics
Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company focused on the development of better treatments for brain disease.
$
Chase Therapeutics revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the current industry and current estimated revenues | $547,552 |
| Total funding | $20,000,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Employees by Department
Chase Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
United Kingdom
AustraliaFrequently asked questions
Chase Therapeutics is located in Washington, District of Columbia, US.
You can reach Chase Therapeutics at +12025688831.
Chase Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
Chase Therapeutics has raised a total of $20,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.
4.8
40,000 users
